Waters Corporation, a global leader in analytical instruments, is set to announce its fiscal Q3 earnings for 2025 on Nov. 4. Analysts expect a profit of $3.21 per share, up 9.6% from the year-ago quarter, with a promising track record of beating estimates. For fiscal 2025, a profit of $12.99 per share is expected, representing a 9.5% increase from fiscal 2024. WAT shares have underperformed the S&P 500 but outpaced the Health Care Select Sector SPDR Fund. Despite strong Q2 results, shares dipped on concerns over the acquisition of BDX’s biosciences and diagnostics unit. Analysts rate WAT stock as a “Moderate Buy” with a mean price target of $362.36.

Read more at Barchart: What You Need to Know Ahead of Waters Corporation’s Earnings Release